ReviewJTO clinical and research reports2025

Phase 3 Trials of Neoadjuvant, Perioperative, and Adjuvant Chemoimmunotherapy for Resectable, Early-Stage NSCLC: Comprehensive Review and Detailed Analysis.

Jay M Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.